Clover Health Investments (CLOV) Projected to Post Quarterly Earnings on Tuesday

Posted by Chris Copeland on Mar 4th, 2025

Clover Health Investments (NASDAQ:CLOV – Get Free Report) is projected to post its quarterly earnings results before the market opens on Tuesday, March 11th. Analysts expect Clover Health Investments to post earnings of ($0.07) per share and revenue of $346.92 million for the quarter. Individual interested in registering for the company’s earnings conference call can do so using this link.

Clover Health Investments Trading Down 8.3 %

CLOV stock opened at $3.64 on Tuesday. The business’s 50-day moving average price is $4.05 and its two-hundred day moving average price is $3.60. The firm has a market cap of $1.82 billion, a PE ratio of -18.20 and a beta of 1.99. Clover Health Investments has a 1-year low of $0.61 and a 1-year high of $4.87.

Analysts Set New Price Targets

Several research analysts have weighed in on the company. Craig Hallum assumed coverage on Clover Health Investments in a report on Tuesday, December 17th. They set a “buy” rating and a $6.00 target price on the stock. Canaccord Genuity Group boosted their price target on Clover Health Investments from $4.20 to $4.50 and gave the company a “buy” rating in a report on Monday.

Read Our Latest Stock Report on CLOV

Clover Health Investments Company Profile

(Get Free Report)

Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat.